(HLN) Haleon - Performance 21% in 12m
Compare HLN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
51.93%
#9 in Group
Rel. Strength
75.75%
#1936 in Universe
Total Return 12m
20.99%
#42 in Group
Total Return 5y
41.14%
#32 in Group
P/E 24.4
64th Percentile in Group
P/E Forward 20.2
71th Percentile in Group
PEG 1.79
88th Percentile in Group
FCF Yield 4.86%
88th Percentile in Group
12m Total Return: HLN (21%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: HLN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HLN
Total Return (including Dividends) | HLN | XBI | S&P 500 |
---|---|---|---|
1 Month | -0.23% | 2.28% | -0.87% |
3 Months | 8.41% | -10.48% | -7.58% |
12 Months | 20.99% | -1.83% | 11.88% |
5 Years | 41.14% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | HLN | XBI | S&P 500 |
1 Month | 58.2% | 56.6% | 23% |
3 Months | 42.1% | -89.3% | -88.5% |
12 Months | 59.8% | -42.4% | 55.1% |
5 Years | 88.7% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #115 | -2.45% | 0.64% |
3 Month | #29 | 21.1% | 17.3% |
12 Month | #43 | 23.2% | 8.14% |
5 Years | #38 | 35.5% | -6.56% |
FAQs
Does HLN Haleon outperforms the market?
Yes,
over the last 12 months HLN made 20.99%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months HLN made 8.41%, while XBI made -10.48%.
Over the last 3 months HLN made 8.41%, while XBI made -10.48%.
Performance Comparison HLN vs Indeces and Sectors
HLN vs. Indices HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.21% | 0.64% | 7.81% | 9.11% |
US NASDAQ 100 | QQQ | -4.24% | -1.63% | 7.38% | 8.32% |
US Dow Jones Industrial 30 | DIA | -2.27% | 2.95% | 7.90% | 11.8% |
German DAX 40 | DAX | -1.98% | -1.55% | -11.7% | -3.69% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.75% | 2.59% | 10.8% | 15.0% |
Hongkong Hang Seng | HSI | -2.22% | -0.29% | 5.89% | 7.10% |
India NIFTY 50 | INDA | -0.37% | -4.29% | 7.52% | 17.9% |
Brasil Bovespa | EWZ | -2.41% | -4.83% | 4.11% | 26.8% |
HLN vs. Sectors HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.46% | 0.82% | 1.68% | -2.97% |
Consumer Discretionary | XLY | -3.29% | -0.13% | 5.30% | 7.67% |
Consumer Staples | XLP | 0.29% | -0.43% | 2.50% | 9.79% |
Energy | XLE | 1.27% | 13.6% | 13.6% | 32.1% |
Financial | XLF | -1.82% | 1.88% | 0.21% | -1.70% |
Health Care | XLV | -3.13% | 3.56% | 9.50% | 19.3% |
Industrial | XLI | -3.63% | -0.34% | 7.10% | 11.4% |
Materials | XLB | -2.60% | 2.20% | 15.2% | 24.5% |
Real Estate | XLRE | -1.69% | 1.08% | 8.70% | 2.90% |
Technology | XLK | -5.66% | -1.92% | 11.2% | 13.3% |
Utilities | XLU | -0.37% | -0.29% | 5.69% | -0.84% |
Aerospace & Defense | XAR | -4.16% | -6.62% | -5.72% | -5.58% |
Biotech | XBI | -4.51% | -2.51% | 20.5% | 22.8% |
Homebuilder | XHB | -2.52% | 2.04% | 22.6% | 28.0% |
Retail | XRT | -1.64% | 0.33% | 13.4% | 23.7% |